Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects - PubMed (original) (raw)

Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects

Sangeeta R Kashyap et al. J Clin Endocrinol Metab. 2005 Feb.

Abstract

Type 2 diabetes is an insulin-resistant state characterized by hyperinsulinemia and accelerated atherosclerosis. In vitro and in vivo studies in rodents have suggested that nitric oxide generation plays an important role in glucose transport and insulin action. We determined nitric oxide synthase (NOS) activity in skeletal muscle of 10 type 2 diabetic (hemoglobin A(1C) = 6.8 +/- 0.1%) and 11 control subjects under basal conditions and during an 80 mU/m(2).min euglycemic insulin clamp performed with vastus lateralis muscle biopsies before and after 4 h of insulin. In diabetics, insulin-stimulated glucose disposal (Rd) was reduced by 50%, compared with controls (5.4 +/- 0.3 vs. 10.4 +/- 0.5 mg/kg.min, P < 0.01). Basal NOS activity was markedly reduced in the diabetic group (101 +/- 33 vs. 457 +/- 164 pmol/min.mg protein, P < 0.05). In response to insulin, NOS activity increased 2.5-fold in controls after 4 h (934 +/- 282 pmol/min.mg protein, P < 0.05 vs. basal), whereas insulin failed to stimulate NOS activity in diabetics (86 +/- 28 pmol/min.mg protein, P = NS from basal). Basal NOS protein content in muscle was similar in controls and diabetics and did not change following insulin. In controls, insulin-stimulated NOS activity correlated inversely with fasting plasma insulin concentration (r = -0.58, P = 0.05) and positively with Rd (r = 0.71, P = 0.03). In control and diabetic groups collectively, Rd correlated with insulin-stimulated NOS activity (r = 0.52, P = 0.02). We conclude that basal and insulin-stimulated muscle NOS activity is impaired in well-controlled type 2 diabetic subjects, and the defect in insulin-stimulated NOS activity correlates closely with the severity of insulin resistance. These results suggest that impaired NOS activity may play an important role in the insulin resistance in type 2 diabetic individuals.

PubMed Disclaimer

Cited by

Unexplained Residual Risk In Type 2 Diabetes: How Big Is The Problem?
Neppala S, Rajan J, Yang E, DeFronzo RA. Neppala S, et al. Curr Cardiol Rep. 2024 Jun;26(6):623-633. doi: 10.1007/s11886-024-02055-0. Epub 2024 Apr 18. Curr Cardiol Rep. 2024. PMID: 38634964 Review.
Insulin resistance/hyperinsulinemia: an important cardiovascular risk factor that has long been underestimated.
Fazio S, Mercurio V, Tibullo L, Fazio V, Affuso F. Fazio S, et al. Front Cardiovasc Med. 2024 Mar 13;11:1380506. doi: 10.3389/fcvm.2024.1380506. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38545338 Free PMC article.
An enzyme that selectively S-nitrosylates proteins to regulate insulin signaling.
Zhou HL, Grimmett ZW, Venetos NM, Stomberski CT, Qian Z, McLaughlin PJ, Bansal PK, Zhang R, Reynolds JD, Premont RT, Stamler JS. Zhou HL, et al. Cell. 2023 Dec 21;186(26):5812-5825.e21. doi: 10.1016/j.cell.2023.11.009. Epub 2023 Dec 5. Cell. 2023. PMID: 38056462
A Descriptive Review of the Action Mechanisms of Berberine, Quercetin and Silymarin on Insulin Resistance/Hyperinsulinemia and Cardiovascular Prevention.
Bellavite P, Fazio S, Affuso F. Bellavite P, et al. Molecules. 2023 Jun 1;28(11):4491. doi: 10.3390/molecules28114491. Molecules. 2023. PMID: 37298967 Free PMC article. Review.
A Metabolomics-Based Investigation of the Effects of a Short-Term Body Weight Reduction Program in a Cohort of Adolescents with Obesity: A Prospective Interventional Clinical Study.
Rigamonti AE, Frigerio G, Caroli D, De Col A, Cella SG, Sartorio A, Fustinoni S. Rigamonti AE, et al. Nutrients. 2023 Jan 19;15(3):529. doi: 10.3390/nu15030529. Nutrients. 2023. PMID: 36771236 Free PMC article.

Insulin resistance is associated with impaired nitric oxide synthase activity in skeletal muscle of type 2 diabetic subjects - PubMed (original) (raw)